{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:13:24Z","timestamp":1793157204077,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":95,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.seminhematol.2026.03.001","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:58:04Z","timestamp":1772841484000},"page":"493-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stem cell transplantation and gene therapy for telomere biology disorders: Historical perspective, current approaches, and emerging strategies"],"prefix":"10.1053","volume":"62","author":[{"given":"Jane","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen D","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani C","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneet","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0001","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0003","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/hematology.2022000394","article-title":"Dyskeratosis congenita and telomere biology disorders","volume":"2022","author":"Savage","year":"2022","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0004","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1046\/j.1365-2141.2000.02109.x","article-title":"Dyskeratosis congenita in all its forms","volume":"110","author":"Dokal","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.001_bib0007","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.001_bib0008","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation","volume":"11","author":"de la Fuente","year":"2007","journal-title":"Pediatr Transplant"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/sj.bmt.1700674","article-title":"Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation","volume":"19","author":"Yabe","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2141.1991.tb04543.x","article-title":"Late vascular complications after bone marrow transplantation for dyskeratosis congenita","volume":"79","author":"Berthou","year":"1991","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","article-title":"Unusual complications after bone marrow transplantation for dyskeratosis congenita","volume":"103","author":"Rocha","year":"1998","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0012","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0014","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hoc.2018.04.003","article-title":"Evaluation and management of hematopoietic failure in dyskeratosis congenita","volume":"32","author":"Agarwal","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.03.001_bib0015","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2017-05-781799","article-title":"Inherited bone marrow failure syndromes: considerations pre- and posttransplant","volume":"130","author":"Alter","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0016","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.15495","article-title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","volume":"183","author":"Fioredda","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0017","unstructured":"Telomere Biology Disorders Diagnosis and Management Guidelines 2nd ed. Team Telomere; New York, 2022."},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.001_bib0018","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0019","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1111\/bjh.19767","article-title":"Haematological features of telomere biology disorders diagnosed in adulthood: a French nationwide study of 127 patients","volume":"205","author":"Maillet","year":"2024","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00320601","article-title":"Marrow transplantation for pancytopenia in dyskeratosis congenita","volume":"51","author":"Mahmoud","year":"1985","journal-title":"Blut"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0021","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1365-2141.1996.424984.x","article-title":"Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita","volume":"92","author":"Langston","year":"1996","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0022","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbmt.2016.01.026","article-title":"A reduced-intensity conditioning regimen for patients with dyskeratosis congenita undergoing hematopoietic stem cell transplantation","volume":"22","author":"Nelson","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.07.007","article-title":"Allogeneic hematopoietic cell transplant for bone marrow failure or myelodysplastic syndrome in dyskeratosis congenita\/telomere biology disorders: single-center, single-arm, open-label trial of reduced-intensity conditioning without radiation","volume":"30","author":"Dimitrov","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/bmt.2013.35","article-title":"Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure","volume":"48","author":"Ayas","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0025","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29177","article-title":"Reduced-intensity conditioning-based hematopoietic cell transplantation for dyskeratosis congenita: single-center experience and literature review","volume":"68","author":"Bhoopalan","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0026","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/16078454.2021.1876393","article-title":"Hematopoietic stem cell transplantation for inherited bone marrow failure syndromes: alternative donor and disease-specific conditioning regimen with unmanipulated grafts","volume":"26","author":"Lu","year":"2021","journal-title":"Hematology"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0027","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ejh.14023","article-title":"Hematopoietic cell transplantation for telomere biology diseases: a retrospective single-center cohort study","volume":"111","author":"Nichele","year":"2023","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000318721","article-title":"Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenita","volume":"124","author":"Vuong","year":"2010","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0029","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2141.2002.03822.x","article-title":"A novel DKC1 mutation, severe combined immunodeficiency (T+B-NK- SCID) and bone marrow transplantation in an infant with Hoyeraal-Hreidarsson syndrome","volume":"119","author":"Cossu","year":"2002","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.bmt.1703931","article-title":"Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenita","volume":"31","author":"Dror","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0031","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/sj.bmt.1703844","article-title":"Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of dyskeratosis congenita","volume":"31","author":"Gungor","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0032","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3046.2010.01431.x","article-title":"Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita","volume":"15","author":"Nishio","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.001_bib0033","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/bmt.2011.257","article-title":"A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita","volume":"47","author":"Kharfan-Dabaja","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0034","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/bmt.2015.333","article-title":"Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita","volume":"51","author":"Brown","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0035","unstructured":"Suneet Agarwal KM, Joseph A, Alison B, et al. Hematopoietic cell transplantation without radiation or dna alkylating agents in bone marrow failure with short telomeres. Bone Marrow Transplantation; 54:116-141. https:\/\/www.nature.com\/articles\/s41409-019-0562-9"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0036","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood.2021011075","article-title":"The clinical and functional effects of TERT variants in myelodysplastic syndrome","volume":"138","author":"Reilly","year":"2021","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.001_bib0037","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2011.06.004","article-title":"Telomere biology in hematopoiesis and stem cell transplantation","volume":"25","author":"Gadalla","year":"2011","journal-title":"Blood Rev"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0038","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.001_bib0039","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00439-021-02257-4","article-title":"High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders","volume":"140","author":"Norris","year":"2021","journal-title":"Hum Genet"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0040","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/hmg\/5.5.685","article-title":"Heterogeneity in telomere length of human chromosomes","volume":"5","author":"Lansdorp","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0041","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng1084","article-title":"Extensive allelic variation and ultrashort telomeres in senescent human cells","volume":"33","author":"Baird","year":"2003","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0042","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41467-017-01291-z","article-title":"A method for measuring the distribution of the shortest telomeres in cells and tissues","volume":"8","author":"Lai","year":"2017","journal-title":"Nat Commun"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.001_bib0043","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1016\/j.transproceed.2013.02.137","article-title":"Fludarabine, low-dose cyclophosphamide and rabbit antithymocyte globulin allowed stable engraftment after allogeneic peripheral blood stem cell transplantation for poly-transfused dyskeratosis congenita patient: case report","volume":"45","author":"Colita","year":"2013","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14157","article-title":"Non-myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita","volume":"26","author":"Gibson","year":"2022","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1365-2141.2002.03835_2.x","article-title":"Successful umbilical cord blood transplantation in a child with dyskeratosis congenita after a fludarabine-based reduced-intensity conditioning regimen","volume":"119","author":"Nobili","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0046","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0047","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/sci.2019.10.04","article-title":"Cord blood transplantation for bone marrow failure syndromes: state of art","volume":"6","author":"Pagliuca","year":"2019","journal-title":"Stem Cell Investig"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0048","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MPH.0000000000000283","article-title":"Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen","volume":"37","author":"Algeri","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0049","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bmt.2015.352","article-title":"TCR alphabeta and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation","volume":"51","author":"Bhattacharyya","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.001_bib0050","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":"Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.03.001_bib0051","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.2169\/internalmedicine.55.7462","article-title":"Fatal hemorrhagic gastrointestinal angioectasia after bone marrow transplantation for dyskeratosis congenita","volume":"55","author":"Imai","year":"2016","journal-title":"Intern Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0052","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/MPH.0000000000000208","article-title":"Diffuse hemorrhagic colitis in a patient with dyskeratosis congenita after nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Ehlert","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0053","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/MPH.0b013e318279e5ca","article-title":"Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation","volume":"35","author":"Isoda","year":"2013","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.101355","article-title":"Simultaneous liver and kidney transplantation in a patient with telomere biology disorder: a case study","volume":"14","author":"Choudhary","year":"2024","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0055","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhep.2021.07.022","article-title":"Outcomes following liver transplant in adults with telomere biology disorders","volume":"76","author":"Penrice","year":"2022","journal-title":"J Hepatol"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.001_bib0056","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000462","article-title":"Liver disease and transplantation in telomere biology disorders: an international multicenter cohort","volume":"8","author":"Wang","year":"2024","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.001_bib0057","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11899-024-00724-z","article-title":"Pulmonary, hepatic, and allogeneic hematopoietic stem cell transplantation in patients with telomere biology disorders","volume":"19","author":"Pennington","year":"2024","journal-title":"Curr Hematol Malig Rep"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.001_bib0058","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.bbmt.2014.04.008","article-title":"Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.001_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162409","article-title":"Association of donor and recipient telomere length with clinical outcomes following lung transplantation","volume":"11","author":"Courtwright","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0060","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00003-2020","article-title":"Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival","volume":"6","author":"Courtwright","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0061","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2326-11-3","article-title":"Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: case report and systematic literature review","volume":"11","author":"Giri","year":"2011","journal-title":"BMC Blood Disord"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.001_bib0062","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/TP.0000000000002198","article-title":"Multiple solid organ transplantation in telomeropathy: case series and literature review","volume":"102","author":"Lebeer","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.001_bib0063","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2017.02.005","article-title":"Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival","volume":"36","author":"Newton","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.001_bib0064","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(14)70124-9","article-title":"Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation","volume":"2","author":"Stuart","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chest.2019.03.030","article-title":"Lung transplant outcomes in patients with pulmonary fibrosis with telomere-related gene variants","volume":"156","author":"Swaminathan","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0066","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.2010.08212.x","article-title":"Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study","volume":"150","author":"Alter","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0067","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","article-title":"Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning","volume":"117","author":"Majhail","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2026.03.001_bib0068","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1182\/bloodadvances.2024012693","article-title":"Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry","volume":"8","author":"Schonfeld","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0069","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1066896912468214","article-title":"Posttransplant lymphoproliferative disorder complicating hematopoietic stem cell transplantation in a patient with dyskeratosis congenita","volume":"21","author":"Bohn","year":"2013","journal-title":"Int J Surg Pathol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.001_bib0070","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.001_bib0071","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31757","article-title":"Analysis of late complications associated with hematopoietic stem cell transplantation in patients with dyskeratosis congenita","volume":"72","author":"Koike","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0072","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbmt.2016.10.004","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.001_bib0073","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbmt.2017.05.022","volume":"23","author":"Dietz","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0074","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1182\/hematology.2020000095","article-title":"Special pre- and posttransplant considerations in inherited bone marrow failure and hematopoietic malignancy predisposition syndromes","volume":"2020","author":"Bonfim","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jpeds.2020.09.038","article-title":"Gastrointestinal hemorrhage: a manifestation of the telomere biology disorders","volume":"230","author":"Himes","year":"2021","journal-title":"J Pediatr"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.001_bib0076","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/hep.30578","article-title":"The spectrum of hepatic involvement in patients with telomere disease","volume":"69","author":"Kapuria","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0077","article-title":"Avascular necrosis and minimal trauma fractures in telomere biology disorders","author":"Niknafs","year":"2025","journal-title":"Clin Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.001_bib0078","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400252","article-title":"Clinical use of ZSCAN4 for telomere elongation in hematopoietic stem cells","volume":"4","author":"Myers","year":"2025","journal-title":"NEJM Evid"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.001_bib0079","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/emmm.201200245","article-title":"Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer","volume":"4","author":"Bernardes de Jesus","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1096\/fj.14-259531","article-title":"Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells","volume":"29","author":"Ramunas","year":"2015","journal-title":"FASEB J"},{"key":"10.1053\/j.seminhematol.2026.03.001_bib0081","doi-asserted-by":"crossref","DOI":"10.1038\/celldisc.2017.34","article-title":"Systematic analysis of human telomeric dysfunction using inducible telosome\/shelterin CRISPR\/Cas9 knockout cells","volume":"3","author":"Kim","year":"2017","journal-title":"Cell Discov"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.001_bib0082","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","article-title":"Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0083","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10418-7","article-title":"CRISPR\/Cas9-induced transgene insertion and telomere-associated truncation of a single human chromosome for chromosome engineering in CHO and A9 cells","volume":"7","author":"Uno","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0084","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1378\/chest.15-0825","article-title":"Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders","volume":"148","author":"Gorgy","year":"2015","journal-title":"Chest"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10456-018-9640-7","article-title":"Understanding the evolving phenotype of vascular complications in telomere biology disorders","volume":"22","author":"Higgs","year":"2019","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.001_bib0086","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00209-2019","article-title":"Prognostic significance of pulmonary function tests in dyskeratosis congenita, a telomere biology disorder","volume":"5","author":"Giri","year":"2019","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.001_bib0087","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01640-2016","article-title":"Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders","volume":"49","author":"Khincha","year":"2017","journal-title":"Eur Respir J"},{"issue":"169","key":"10.1053\/j.seminhematol.2026.03.001_bib0088","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0251-2022","article-title":"Multiple breath washout and oscillometry after allogenic HSCT: a scoping review","volume":"32","author":"Sonneveld","year":"2023","journal-title":"Eur Respir Rev"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0089","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01779-2018","article-title":"Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry","volume":"53","author":"Walkup","year":"2019","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.001_bib0090","doi-asserted-by":"crossref","first-page":"omae049","DOI":"10.1093\/omcr\/omae049","article-title":"Dyskeratosis congenita: a rare case report","volume":"2024","author":"Khattab","year":"2024","journal-title":"Oxf Med Case Rep"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:55:15Z","timestamp":1781027715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0037196326000156"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.03.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cell transplantation and gene therapy for telomere biology disorders: Historical perspective, current approaches, and emerging strategies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}